Prevention of gallstones by ursodeoxycholic acid after cardiac surgery

Journal of Gastroenterology

Volumn 38, Issue 11, 2003, Pages 1071-1076

  Ai, Toshiji ^a   Azemoto, Ryosaku ^a   Saisho, Hiromitsu ^b  

^a CHIBA CARDIOVASCULAR CENTER   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiac surgery; Gallstone prevention; Ursodeoxycholic acid

Indexed keywords

BILIRUBIN; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; ECHOGRAPHY; FEMALE; GALLSTONE FORMATION; HEART LUNG MACHINE; HEART SURGERY; HEART VALVE PROSTHESIS; HEMOLYSIS; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RETICULOCYTE COUNT;

ADOLESCENT; ADULT; AGED; CARDIOPULMONARY BYPASS; CHOLAGOGUES AND CHOLERETICS; FEMALE; GALLBLADDER; GALLSTONES; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; URSODEOXYCHOLIC ACID;

EID: 0345860909     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00535-003-1198-4     Document Type: Article

References (23)

1. Merendino KA, Manhas DR. Man-made gallstones: a new entity following cardiac valve replacement. Ann Surg 1973;177:694-704.
2. Harrison EC, Roschke EJ, Meyers HI, Edmiston WA, Chan LS, Tatter D, et al. Cholelithiasis: a frequent complication of artificial heart valve replacement. Am Heart J 1978;95:483-8.
3. Azemoto R, Tsuchiya Y, Ai T, Murayama H, Nakagawa Y, Saisho H, et al. Does gallstone formation after open cardiac surgery result only from latent hemolysis by replaced valves? Am J Gastroenterol 1996;91:2185-9.
4. Yazawa T, Tsuchiya Y, Saisho H, Ohto M. Jpn J Gastroenterol 1988;85:708-14.
5. Sharma BC, Agarwal DK, Dhiman RK, Baijal SS, Choudhuri G, Saraswat VA, et al. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy. Gastroenterology 1998;115:124-8.
6. Trotman BW. Pigment gallstone disease. Gastroenterol Clin North Am 1991;20:111-26.
7. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, et al. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000;30:317-24.
8. Usui R, Ise H, Kitayama O, Suzuki N, Matsuno S. Pathogenesis of black gallstones associated with hemolytic disease. Jpn J Gastroenterol 1991;88:1426-35.
9. Cetta F. The role of bacteria in pigment gallstone disease. Ann Surg 1991;213:315-26.
10. Trotman BW. Pigment gallstone disease. Gastroenterol Clin North Am 1991;20:111-26.
11. Usui R, Ise H, Suzuki N, Matsuno S. Factors affecting ionized calcium concentration in human bile. Gastroenterol Jpn 1990; 25(3):403.
12. Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 1999;116:1420-7.
13. Lee KT, Liu TS. Mucin gene expression in gallbladder epithelium with black pigment stone ascertained by in situ hybridization. Kaohsiung J Med Sci 2001;17:517-23.
14. Van Erpecum KJ, Portincasa P, Eckhardt E, Go PM, VanBerge-Henegouwen GP, Groen AK. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile. Gastroenterology 1996;110:1225-37.
15. Malavolti M, Fromm H, Ceryak S, Shehan KL. Effects of bile acid depletion and of ursodeoxycholic and chenodeoxycholic acids on biliary protein secretion in the hamster. Life Sci 1990;46:1727-37.
16. Portincasa P, Di Ciaula A, Vendemiale G, Palmieri V, Moschetta A, Vanberge-Henegouwen GP, et al. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000;30:317-24.
17. Portincasa P, DiCiaula A, Palmieri V, Velardi A, Van Berge-Henegouwen GP, Palasciano G. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects. Ital J Gastroenterol 1996;28:111-3.
18. Kuniyuki H, Tuchiya K, Oto M. A clinical study of effect of ursodeoxycholic acid on gallbladder contractility in gallstone patients. J Jpn Biliary Assoc 1994;8:429-38.
19. Festi D, Frabboni R, Bazzoli F, Sangermano A, Ronchi M, Rossi L, et al. Gallbladder motility in cholesterol gallstone disease. Effect of ursodeoxycholic acid administration and gallstone dissolution. Gastroenterology 1990;99:1779-85.
20. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994;19:1149-56.
21. Shimokura GH, McGill JM, Schlenker T, Fitz JG. Ursodeoxycholate increases cytosolic calcium concentration and activates Cl-currents in a biliary cell line. Gastroenterology 1995;109:965-72.
22. Galan AI, Jimenez R, Munoz ME, Gonzalez J. Effects of ursodeoxycholate on maximal biliary secretion of bilirubin in the rat. Biochem Pharmacol 1990;39:1175-80.
23. Lanzini A, Northfield TC. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid. Gut 1990;31:226-30.